Adverum Biotechnologies, Inc. (ADVM)

Last Closing Price: 2.12 (2025-05-16)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Adverum Biotechnologies, Inc. (ADVM) had Net Income of $-130.93M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$1.00M
Net Income
$-130.93M
--
$1.00M
$140.16M
$-139.16M
$8.23M
$-130.93M
$-130.93M
$-130.93M
$-130.93M
$-130.93M
$-130.93M
$-139.16M
$-137.41M
19.78M
19.78M
$-6.62
$-6.62
Balance Sheet Financials
$131.30M
$11.61M
$48.54M
$179.84M
$22.90M
--
$86.23M
$109.13M
$70.71M
$70.71M
$70.71M
20.85M
Cash Flow Statement Financials
$-92.46M
$-41.89M
$120.00M
$76.98M
$62.63M
$-14.35M
$14.35M
--
--
Fundamental Metrics & Ratios
5.73
--
--
--
--
100.00%
-13915.90%
-13915.90%
-13741.30%
-13092.70%
-13092.70%
$-92.85M
--
--
--
0.01
--
--
--
-185.15%
-185.15%
-72.80%
-185.15%
$3.39
$-4.69
$-4.67